FPH Overzicht aandelen
Fisher & Paykel Healthcare Corporation Limited ontwerpt, produceert, verkoopt en verkoopt samen met haar dochterondernemingen producten en systemen voor medische hulpmiddelen in Noord-Amerika, Europa, Azië en het Stille-Oceaangebied. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 0/6 |
| Toekomstige groei | 5/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 6/6 |
| Dividenden | 0/6 |
Fisher & Paykel Healthcare Corporation Limited Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | NZ$38.55 |
| 52 Week Hoogtepunt | NZ$38.87 |
| 52 Week Laag | NZ$21.83 |
| Bèta | 0.39 |
| 11 maand verandering | 4.02% |
| 3 maanden verandering | 8.90% |
| 1 Jaar Verandering | 73.03% |
| 33 jaar verandering | 18.25% |
| 5 jaar verandering | 74.04% |
| Verandering sinds IPO | 8,466.67% |
Recent nieuws en updates
The Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Don't Inspire Confidence
Oct 28
Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shares May Have Run Too Fast Too Soon
Oct 08Recent updates
The Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Don't Inspire Confidence
Oct 28Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shares May Have Run Too Fast Too Soon
Oct 08Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns
Aug 21Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Jul 29Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends
Jul 11Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Investors Are Less Pessimistic Than Expected
Jun 22There May Be Reason For Hope In Fisher & Paykel Healthcare's (NZSE:FPH) Disappointing Earnings
Jun 05Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?
Mar 27Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Feb 22Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price
Feb 05Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate
Jan 03We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt
Nov 30Fisher & Paykel Healthcare (NZSE:FPH) Could Be Struggling To Allocate Capital
Nov 12Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Aug 28Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Aug 10Here's Why Fisher & Paykel Healthcare (NZSE:FPH) Can Manage Its Debt Responsibly
Jul 02Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
May 01Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)
Jan 23Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Dec 27Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Oct 28Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value
Oct 13Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet
Sep 28Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Jul 24A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital
Jul 10Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly
Jun 12A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Apr 17Fisher & Paykel Healthcare (NZSE:FPH) Could Become A Multi-Bagger
Apr 04Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Mar 06With EPS Growth And More, Fisher & Paykel Healthcare (NZSE:FPH) Is Interesting
Jan 22Why The 41% Return On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Should Have Your Attention
Dec 26Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Dec 05This Is The Reason Why We Think Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Deserves A Bump Up To Their Compensation
Aug 11Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Worth NZ$31.6 Based On Its Intrinsic Value?
Aug 01Do Fisher & Paykel Healthcare's (NZSE:FPH) Earnings Warrant Your Attention?
Jul 07Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Jun 24Rendement voor aandeelhouders
| FPH | NZ Medical Equipment | NZ Markt | |
|---|---|---|---|
| 7D | 4.1% | -0.3% | 0.2% |
| 1Y | 73.0% | 30.4% | 9.5% |
Rendement versus industrie: FPH overtrof de NZ Medical Equipment industrie, die het afgelopen jaar een rendement 30.4 % opleverde.
Rendement versus markt: FPH overtrof de NZ markt, die het afgelopen jaar een rendement opleverde van 9.5 %.
Prijsvolatiliteit
| FPH volatility | |
|---|---|
| FPH Average Weekly Movement | 4.7% |
| Medical Equipment Industry Average Movement | 9.1% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in NZ Market | 8.9% |
| 10% least volatile stocks in NZ Market | 3.0% |
Stabiele aandelenkoers: FPH heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 5% ) van FPH is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1934 | 7,005 | Lewis Gradon | www.fphcare.com |
Fisher & Paykel Healthcare Corporation Limited ontwerpt, produceert, verkoopt en verkoopt samen met haar dochterondernemingen producten en systemen voor medische hulpmiddelen in Noord-Amerika, Europa, Azië en het Stille-Oceaangebied. Het bedrijf levert zijn producten voor gebruik in acute en chronische ademhalingszorg en chirurgie, evenals voor de behandeling van obstructieve slaapapneu (OSA) thuis en in het ziekenhuis. Het bedrijf biedt ook ademhalingsproducten voor volwassenen, waaronder optiflow nasale high flow-therapie, invasieve beademing en niet-invasieve beademing.
Fisher & Paykel Healthcare Corporation Limited Samenvatting
| FPH fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | NZ$21.66b |
| Inkomsten(TTM) | NZ$132.60m |
| Inkomsten(TTM) | NZ$1.74b |
170.4x
Koers/Winstverhouding13.0x
P/S-verhoudingIs FPH overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| FPH resultatenrekening (TTM) | |
|---|---|
| Inkomsten | NZ$1.74b |
| Kosten van inkomsten | NZ$698.40m |
| Brutowinst | NZ$1.04b |
| Overige uitgaven | NZ$911.80m |
| Inkomsten | NZ$132.60m |
Laatst gerapporteerde inkomsten
Mar 31, 2024
Volgende inkomensdatum
Nov 27, 2024
| Winst per aandeel (EPS) | 0.23 |
| Brutomarge | 59.93% |
| Nettowinstmarge | 7.61% |
| Schuld/Eigen Vermogen Verhouding | 6.5% |
Hoe presteerde FPH op de lange termijn?
Bekijk historische prestaties en vergelijking